Anti-SEMA4D Monoclonal Antibody VX15/2503
IRB00098707
Phase 1 mab completed
Quick answer
Anti-SEMA4D Monoclonal Antibody VX15/2503 for Colon Carcinoma Metastatic in the Liver is a Phase 1 program (mab) at VACCINEX, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- VACCINEX, INC.
- Indication
- Colon Carcinoma Metastatic in the Liver
- Phase
- Phase 1
- Modality
- mab
- Status
- completed